Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01437293 · ClinicalTrials.gov registry record · Phase 1
Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)
A Phase 1 study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT01437293 is a Phase 1 study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 15 participants.
The verdict
NCT01437293, a Phase 1 study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
An inpatient safety study to characterize the cardiovascular and behavioral effects of cocaine administration in the presence of LCE. The proposed study involves an inpatient stay of 12 days during which participants will have two cocaine-administration sessions, each including five doses of smoked cocaine with ascending doses.
Interventions
- DRUG L-dopa / carbidopa / entacapone (LCE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2010-08 |
| Est. Completion | 2012-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01437293
The ClinicalTrials.gov registry entry for NCT01437293 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which L-dopa / carbidopa / entacapone (LCE) is the first listed.
NCT01437293 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01437293 about?
NCT01437293 is a clinical study titled "Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)". An inpatient safety study to characterize the cardiovascular and behavioral effects of cocaine administration in the presence of LCE. The proposed study involves an inpatient stay of 12 days during which participants will have two cocaine-administration sessions, each including five doses of smoked ...
What is the current status of trial NCT01437293?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2010-08. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01437293?
The interventions under investigation include: L-dopa / carbidopa / entacapone (LCE) (DRUG).
Who is sponsoring clinical trial NCT01437293?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.